The future of neuroimmunology research for CNS disease therapeutics

It is an exciting time to be in neuroimmunology research. Promising pharmacological targets and drug approaches for the treatment of diseases of the central nervous system (CNS) are emerging. Jerry Madukwe, the Editor-in-Chief of Trends in Pharmacological Sciences asked authors of the August 2022 special issue to reflect on the global challenges in the field and what they see as the future of neuroimmunology research for CNS disease therapy.